Luca Dozza

Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

Michèle Cavo, Francesca Gay, Meral Beksaç et al. · The Lancet Haematology · 2020 · 377 citations · Full text

Hematological Malignancy, Transplantation, Marrow Transplantation +9

Standardization of ¹⁸F-FDG–PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma

Elena Zamagni, Cristina Nanni, Luca Dozza et al. · Journal of Clinical Oncology · 2020 · 132 citations · Full text

Is there a relationship between self-efficacy, disability, pain and sociodemographic characteristics in chronic low back pain? A multicenter retrospective analysis

Silvano Ferrari, Carla Vanti, Marta Pellizzer et al. · Archives of Physiotherapy · 2019 · 62 citations · Full text

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Paola Tacchetti, Lucia Pantani, Francesca Patriarca et al. · The Lancet Haematology · 2020 · 57 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +12

Double Vs Single Autologous Stem Cell Transplantation for Newly Diagnosed Multiple Myeloma: Long-Term Follow-up (10-Years) Analysis of Randomized Phase 3 Studies

Michèle Cavo, Hartmut Goldschmidt, Laura Rosiñol et al. · Blood · 2018 · 53 citations